Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions reflect a mix of support and concern, with posts referencing the Swedish study and emphasizing that even subsidies do not fully address disparities. The tone ranges from supportive recognition to calls for policy reform, illustrating their relevance and potential influence on health equity debates.
Most posts acknowledge and support the findings that socioeconomic factors influence access to migraine treatments, with some expressing concern about disparities.
Posts show high interest by referencing specific studies, disparities, and policy implications, indicating engagement with the subject.
Discussions include mentions of research details, calls for policy change, and reflections on health equity, demonstrating moderate to deep engagement.
The posts highlight the significance of socioeconomic disparities in healthcare, emphasizing the need for systemic change, suggesting a notable perceived impact.
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s https://t.co/RNgHtkpdL7
A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies for migraine — even with subsidies in place. Paper: https://t.co/Vp7JQWcnsh Podcast: https://t.co/lbqKKRdkry #migraine #headache #CGRP #healthequity https://t.co/ocaXuNPAZG
@MigraineDisordr https://t.co/fsm0BkTWLs Sorry about that
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s https://t.co/4YPmx7ylll
Even when subsidized, those with low SES still did not have access to these potentially life-altering medications. More needs to be done and it starts with education and ends with policy changes. Study: https://t.co/Uk4nfdhiMm #migraine #cerebraltorque #CGRP https://t.co/rSnQXAeAxc
@ihs_official The link doesn't work. Here’s the correct one https://t.co/eGm6KMdj1e
A Swedish study reveals socioeconomic gaps in access to CGRP migraine treatments, with higher income and education levels significantly more likely to receive these advanced therapies, highlighting ongoing health equity…
Professor Simona Sacco hosts an interview discussing how higher socioeconomic status increases the likelihood of receiving CGRP inhibitor treatments for migraine, highlighting possible disparities in access to advanced…
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s https://t.co/4YPmx7ylll
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s https://t.co/RNgHtkpdL7
RT @JCephalalgia: @MigraineDisordr https://t.co/fsm0BkTWLs Sorry about that
@MigraineDisordr https://t.co/fsm0BkTWLs Sorry about that
@ihs_official The link doesn't work. Here’s the correct one https://t.co/eGm6KMdj1e
RT @faradoost: A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies…
RT @faradoost: A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies…
RT @faradoost: A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies…
RT @faradoost: A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies…
A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies for migraine — even with subsidies in place. Paper: https://t.co/Vp7JQWcnsh Podcast: https://t.co/lbqKKRdkry #migraine #headache #CGRP #healthequity https://t.co/ocaXuNPAZG
Even when subsidized, those with low SES still did not have access to these potentially life-altering medications. More needs to be done and it starts with education and ends with policy changes. Study: https://t.co/Uk4nfdhiMm #migraine #cerebraltorque #CGRP https://t.co/rSnQXAeAxc